NAUT — Nautilus Biotechnology Share News
0.000.00%
Last trade - 00:00- $412.31m
- $328.28m
Nautilus Biotechnology Inc expected to post a loss of 17 cents a share - Earnings Preview
Nautilus Biotechnology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Nautilus Biotechnology Q2 EPS USD -0.13
Nautilus Biotechnology Inc expected to post a loss of 15 cents a share - Earnings Preview
Nautilus Biotechnology Inc reports results for the quarter ended in March - Earnings Summary
Brief: Nautilus Biotechnology Reports Q1 EPS of USD -0.12
Brief: Nautilus Biotechnology Reports First Quarter 2023 Financial Results
Brief: Nautilus Biotechnology Inc Says Quarterly Loss Per Share $0.12
Nautilus Biotechnology Inc expected to post a loss of 17 cents a share - Earnings Preview
Nautilus Biotechnology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Nautilus Biotechnology Reports Fourth Quarter 2022 Financial Results
Brief: Nautilus Biotechnology Posts Q4 Loss Per Share Of 11 Cents
Nautilus Biotechnology Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Nautilus Biotechnology Expands To San Diego
Brief: Nautilus Biotechnology Partners With The Translational Genomics Research Institute (Tgen) To Investigate Applications Of Single-Molecule Proteomic Analysis In Diffuse Intrinsic Pontine Glioma (Dipg)
Brief: Nautilus Biotechnology Reports Third Quarter 2022 Financial Results
Brief: Nautilus Biotechnology Reports Quarterly Loss Per Share $0.12
Brief: Nautilus Biotechnology - Net Loss $14.7 Million For Q2 Of 2022, Versus Net Loss Of $10.7 Million For Corresponding Prior Year Period
Brief: Nautilus Biotechnology Appoints Eric Spence As Vice President Of Instrument Engineering